Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;14(1):91-94.
doi: 10.52054/FVVO.14.1.014.

The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation

G Monterossi, L Pedone Anchora, S Gueli Alletti, A Fagotti, F Fanfani, G Scambia

The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation

G Monterossi et al. Facts Views Vis Obgyn. 2022 Mar.

Abstract

Background: The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery.

Objectives: This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device.

Materials and methods: A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Main outcomes measures: Docking and operative times.

Results: The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded.

Conclusion: Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
External view of trocars placement.
Figure 2
Figure 2
The robotic arms after docking.
QR code resolving to https://qrco.de/bcsvLJ
See this image and copyright information in PMC

References

    1. Aarts JW, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;2015:CD003677 - PMC - PubMed
    1. Albright BB, Witte T, Tofte AN, et al. Robotic versus laparoscopic hysterectomy for benign disease: a systematic review and meta-analysis of randomized trials. J Minim Invasive Gynecol. 2016;23:18–27. - PMC - PubMed
    1. Fanfani F, Restaino S, Gueli Alletti S, et al. TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes. J Minim Invasive Gynecol. 2015;22:1011–1017. - PubMed
    1. Fanfani F, Monterossi G, Fagotti A, et al. The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc. 2016a;30:215–221. - PubMed
    1. Fanfani F, Restaino S, Rossitto C, et al. Total Laparoscopic (S-LPS) versus TELELAP ALF-X robotic-assisted hysterectomy: a case-control study. J Minim Invasive Gynecol. 2016b;23:933–938. - PubMed

LinkOut - more resources